Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation

doi:10.3748/wjg.v21.i39.11112

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8955)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

628

WORD

209

HTML

4296

Figures (1-1)

589

Tables (1-1)

504

Sum=6226

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1085

Download

1644

Sum=2729

Oct 21, 2015 (publication date) through Oct 31, 2025

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Gastroenterol. Oct 21, 2015; 21(39): 11112-11117
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11112

Open in New Tab Full Size Figure Download Figure

Figure 1 Algorithm for prophylaxis to prevent de novo hepatitis B virus for recipients of HBcAb(+) grafts. For recipients with pretransplant HBsAb > 1000 IU/L, no antiviral prophylaxis is required. Recipients require nucleos(t)ide analogs if HBsAb is < 1000 IU/L. Post-transplant vaccination is given after steroid withdrawal. Nucleos(t)ide analogs may be discontinued if HBsAb is > 1000 IU/L.

Citation: Lin CC, Yong CC, Chen CL. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation. World J Gastroenterol 2015; 21(39): 11112-11117
URL: https://www.wjgnet.com/1007-9327/full/v21/i39/11112.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i39.11112